Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mary Tabatneck
Observed name:
Mary E. Tabatneck
Institution:
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Observed institutions:
Boston Children's Hospital,
Dana-Farber Cancer Institute,
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
ORCID:
0000-0002-4843-871X
Observed ORCID:
0000-0002-4843-871X
OpenAlex ID:
A5085298071
Pediatric Tuberculosis Infection Care Facilitators and Barriers: A Qualitative Study
2024
·
Yamini Adusumelli
, Mary Tabatneck
, et al.
·
PEDIATRICS
·
9
PDF
Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston
2022
·
Jeffrey I. Campbell
, Mary Tabatneck
, et al.
·
The Journal of Pediatrics
·
8
PDF
Interferon Gamma Release Assay Results and Testing Trends Among Patients Younger Than 2 Years Old at Two US Health Centers
2022
·
Mary E. Tabatneck
, Wei He
, et al.
·
The Pediatric Infectious Disease Journal
·
6
PDF
Increasing Use Of Interferon Gamma Release Assays Among Children ≥2 Years of Age in a Setting With Low Tuberculosis Prevalence
2022
·
Jeffrey I. Campbell
, Mary Tabatneck
, et al.
·
The Pediatric Infectious Disease Journal
·
5
PDF
1864. Recruitment of Participants for Qualitative Research in Marginalized Populations
2023
·
Yamini Adusumelli
, Mary Tabatneck
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
1403. Facilitators and barriers to latent tuberculosis infection diagnosis and care in Massachusetts: a convergent mixed methods study of clinicians
2022
·
Jeffrey Campbell
, Yamini Adusumelli
, et al.
·
Open Forum Infectious Diseases
·
1
1439. Latent tuberculosis infection treatment location and association with care completion
2022
·
Jeffrey Campbell
, Mary Tabatneck
, et al.
·
Open Forum Infectious Diseases
·
1
QOL-03. Excess morbidity and mortality in middle-aged adult survivors of pediatric medulloblastoma: model-based estimates
2025
·
Mary Tabatneck
, Zachary Ward
, et al.
·
Neuro-Oncology Pediatrics
Area-Based Sociodemographic Factors Associated with Latent Tuberculosis Infection in a Low-Prevalence Setting
2023
·
Jeffrey I. Campbell
, Mary Tabatneck
, et al.
·
American Journal of Tropical Medicine and Hygiene
PDF
Outc-07. Analyzing Predictors of Loss to Follow-up as Seen Among Young Survivors of Central Nervous System Tumors for Quality Improvement Interventions at Dana Farber Cancer Institute
2023
·
Tabitha Cooney
, Mary Tabatneck
, et al.
·
Neuro-Oncology
PDF
Qlti-24. Analysis of Disparities in Pediatric Brain Tumor Bank Enrollment as Foundation for Quality Improvement Initiatives at Dana-farber Cancer Institute/boston Children’s Cancer and Blood Disorders Center
2022
·
Mary Tabatneck
, Puja Umaretiya
, et al.
·
Neuro-Oncology
PDF
655. Patterns of Interferon-Gamma Release Assay (IGRA) Testing for Tuberculosis in Patients Less Than 2 Years Old
2021
·
Mary Tabatneck
, Jeffrey Campbell
, et al.
·
Open Forum Infectious Diseases
646. Increasing Use of Interferon-Gamma Release Assay to Test for Pediatric Tuberculosis in a Low-Burden Setting
2021
·
Jeffrey Campbell
, Mingwei Sun
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
13
Citation count:
31
H-index:
4
I10-index:
Year
Topic
Type